TheraRadar
← Back
Data updated: Mar 29, 2026

NOVEL LABS INC

Infectious DiseaseRespiratoryDermatology
Generics

NOVEL LABS INC is a generic drug manufacturer focused on Infectious Disease, Respiratory, Dermatology.

1985
Since
45
Drugs
-
Trials
809
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 54%
7 drugs
Respiratory 15%
2 drugs
Dermatology 15%
2 drugs
Cardiovascular 8%
1 drugs
Gastroenterology 8%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...